Transcatheter aortic valve replacement (TAVR) is increasingly being performed in younger
and lower surgical risk patients. Given the longer life expectancy of these patients, the …

Transcatheter aortic valve replacement is now indicated across all risk categories of patients
with symptomatic severe aortic stenosis and has been proposed as first line option for the …

Since the first groundbreaking procedure in 2002, transcatheter aortic valve implantation
(TAVI) has revolutionized the management of aortic stenosis (AS). Through striking …

Recent guidelines on valvular heart disease in Europe and the United States have
expanded the indications for transcatheter aortic valve implantation (TAVI) to younger …

Transcatheter technologies triggered the recent revision of the guidelines that progressively
widened the indications for the treatment of aortic stenosis. On the surgical realm, a …

Background The implications and potential challenges of coronary access after redo
transcatheter aortic valve replacement (TAVR) are unknown. Objectives The authors sought …

Background Transcatheter aortic valve implantation in an existing transcatheter valve (redo-
TAVI) pins the index valve leaflets in the open position (neoskirt), which can cause coronary …

Background Given enough time, transcatheter heart valves (THVs) will degenerate and may
require reintervention. Redo transcatheter aortic valve implantation (TAVI) is an attractive …

BACKGROUND: Redo-transcatheter aortic valve replacement (TAVR) can pin the index
transcatheter heart valve leaflets open leading to sinus sequestration and restricting …

Transcatheter aortic valve implantation (TAVI) has revolutionised the treatment of severe,
symptomatic aortic stenosis and it is now a proven and effective alternative to surgery for …